These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7026979)

  • 1. Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation.
    Staland B
    Maturitas; 1981 Aug; 3(2):145-56. PubMed ID: 7026979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous treatment with a combination of estrogen and gestagen--a way of avoiding endometrial stimulation. Clinical experiences with Kliogest.
    Staland B
    Acta Obstet Gynecol Scand Suppl; 1985; 130():29-35. PubMed ID: 3859973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
    Hellberg D; Nilsson S
    Maturitas; 1984 Apr; 5(4):233-43. PubMed ID: 6429481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral treatment of menopausal symptoms with natural oestrogens. Experiences with a new series of oestrogens and oestrogen-gestagen combinations.
    Borglin NE; Staland B
    Acta Obstet Gynecol Scand Suppl; 1975; 43():1-11. PubMed ID: 1060357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial and menstrual response to subcutaneous oestradiol and testosterone implants and continuous oral progestogen therapy in post-menopausal women.
    Magos AL; Brincat M; O'Dowd T; Wardle PJ; Schlesinger P; Studd JW
    Maturitas; 1985 Nov; 7(4):297-302. PubMed ID: 4079826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial changes after long-term use of continuous oestrogen and cyclic progestogen.
    Fink BJ
    Maturitas; 1984 Apr; 5(4):277-80. PubMed ID: 6738374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen.
    Mattsson LA; Samsioe G
    Acta Obstet Gynecol Scand Suppl; 1985; 130():53-8. PubMed ID: 3859976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal administration of oestrogen/progestagen hormone replacement therapy.
    Whitehead MI; Fraser D; Schenkel L; Crook D; Stevenson JC
    Lancet; 1990 Feb; 335(8685):310-2. PubMed ID: 1967769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestriol with oestradiol verses oestradiol alone: a comparison of endometrial, symptomatic and psychological effects.
    Padwick ML; Siddle NC; Lane G; Endacott JA; Cooper H; Pryse-Davies J; Whitehead MI
    Br J Obstet Gynaecol; 1986 Jun; 93(6):606-12. PubMed ID: 3524665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment.
    Christiansen C; Christensen MS; Grande P; Transbøl I
    Maturitas; 1984 Mar; 5(3):193-9. PubMed ID: 6727693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimal dose of oral norethindrone acetate for addition to transdermal estradiol: a multicenter study.
    Fraser DI; Parsons A; Whitehead MI; Wordsworth J; Stuart G; Pryse-Davies J
    Fertil Steril; 1990 Mar; 53(3):460-8. PubMed ID: 2407564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
    Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does low-dose, transdermal, norethisterone acetate reliably cause endometrial transformation in postmenopausal oestrogen-users?
    Fraser D; Whitehead M; Schenkel L; Pryse-Davies J
    Maturitas; 1993 Jan; 16(1):23-30. PubMed ID: 8429801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints.
    Sporrong T; Hellgren M; Samsioe G; Mattsson LA
    Br J Obstet Gynaecol; 1988 Oct; 95(10):1042-8. PubMed ID: 3056498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined estrogen and progestogen for the menopause.
    Mugglestone CJ; Swinhoe JR; Craft IL
    Acta Obstet Gynecol Scand; 1980; 59(4):327-9. PubMed ID: 7004052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.
    Helle SI; Omsjø IH; Hughes SC; Botta L; Hüls G; Holly JM; Lønning PE
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):727-32. PubMed ID: 9039339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial effects of transdermal estradiol/norethisterone acetate.
    Lindgren R; Risberg B; Hammar M; Berg G; Pryse-Davies J
    Maturitas; 1992 Aug; 15(1):71-8. PubMed ID: 1528133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
    Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect on endometrium of combined oestrogen-progestogen replacement therapy of 1 mg 17beta-estradiol and 0.5 mg norethisterone acetate.
    Iatrakis G; Tsionis C; Antoniadis S; Kourounis G
    Clin Exp Obstet Gynecol; 2004; 31(1):50-2. PubMed ID: 14998189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and risks of different hormonal replacement therapies in post-menopausal women.
    Volpe A; Facchinetti F; Grasso A; Petraglia F; Campanini D; Genazzani AR
    Maturitas; 1986 Dec; 8(4):327-34. PubMed ID: 3033444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.